Repare Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors (NCT06560632) | Repare Therapeutics | 2024-09-17 |
| LIONS (PLK4 Inhibitor in Advanced Solid Tumors) (NCT06232408) | Repare Therapeutics | 2024-02-14 |
| Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors (NCT04972110) | Repare Therapeutics | 2021-07-21 |
| Study of RP-3500, Camonsertib, in Advanced Solid Tumors (NCT04497116) | Repare Therapeutics | 2020-07-22 |
Track Repare Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.